Evidence map›Paper›PMID 39288966›Full record

ArticleAJNR. American journal of neuroradiology2025

The Many Faces of Myxopapillary Ependymomas.

Ioana Hutuca, Kristof L Egervari, Doron Merkler, Maria Isabel Vargas

Abstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ioana HutucaFrom the Department of Radiology (I.H.), Geneva University Hospitals, Geneva, Switzerland Ioana.hutuca@gmail.com.
Kristof L EgervariDepartment of Neuropathology (K.L.E., D.M.), Geneva University Hospitals, Geneva, Switzerland.
Doron MerklerDepartment of Neuropathology (K.L.E., D.M.), Geneva University Hospitals, Geneva, Switzerland.
Maria Isabel VargasClinique des Grangettes (M.I.V.), Hirslanden, Geneva, Switzerland.ORCID 0000-0002-6571-5336

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myxopapillary ependymomas (MPEs), classified as grade 2 tumors by the World Health Organization, are rare spinal neoplasms. Despite their slow growth and generally benign nature, MPEs have a high recurrence rate and potential for CSF dissemination. This study aims to identify the MRI characteristics and pathologic patterns of MPE and investigate potential correlations between the MRI characteristics and specific histopathologic patterns. We assessed 13 patients (7 men; mean age, 45.1 years) with pathologically proved MPE. MR images were reviewed for tumor location, size, T1 and T2 signal characteristics, contrast enhancement, hemosiderin cap presence, vertebral scalloping, drop metastasis, and prominent intradural flow voids. Four histopathologic patterns (microcystic, solid, hemorrhagic, and high hyalin content) were defined and segmented, with surface areas measured and percentages calculated relative to the total tissue surface. Most tumors were in the lumbar region (84.61%), with MRI revealing typical features such as T2 hyperintensity (100%) and contrast enhancement (92.3%). A rare nonenhancing MPE was noted. Large tumors exhibited a microcystic pathology pattern, with 2 cases with this pattern showing drop metastasis on MRI. Smaller tumors typically presented a solid pathology pattern with homogeneous MRI signals. This study underscores the diverse MRI presentations of MPE and suggests a potential link between microcystic patterns in pathology and large MPE with drop metastasis.

Indexed as

EpendymomaMagnetic Resonance ImagingSpinal Cord NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedYoung Adult

Identifiers

PMID39288966
PMCPMC11979807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.